Too many U.S. seniors are skipping their prescription meds due to cost, and the problem is most acute among the poor and chronically ill, new data shows.
New Medicare rules could make 3.6 million Americans -- or even more -- eligible for treatment with the pricey weight-loss drug Wegovy, a new study finds.
Medicare Advantage plans are touted as a great alternative to traditional Medicare, offering seniors easier access to doctors, hospitals and prescription drugs.
